Orionis Biosciences operates in the healthcare industry focusing on the biotechnology business and innovation.The company is an early-stage drug discovery and development biotechnology company fueled by a suite of disruptive technologies to advance innovative medicines for the treatment of diseases with high unmet medical needs – with an initialinternal focus in oncology and immunotherapies.Orionis Biosciences has research facilities in the Boston area (Headquarters in Waltham, MA, USA) and Ghent (Belgium), and is operated by a world class team of entrepreneurs, scientists and transatlantic network of investors, in concert with strategic research and development collaborations. The latter includes collaborations with VIB (Belgium), Orionis Biosciences co-founding institution.

Biotechnology

Health Care

Health Diagnostics

Orionis Biosciences

Nikolai Kley

Riccardo Sabatini

Robert Petit

James Kyranos

Azza A. Gadir, PhD

Andrew Littlehale

The Leadership Team at Orionis Biosciences is responsible for guiding the strategic vision and operational oversight of the company, ensuring alignment with its goals in drug discovery and development. Comprising experts in technical operations, finance, data science, early clinical development, and chemistry, the team drives innovation and collaboration to advance pioneering therapies in oncology and immunotherapy, enhancing the company’s mission to address unmet medical needs in healthcare.

Leadership Team

Research and Development Team

Operations Team

Leadership Team

About

Team members

Other teams at Orionis Biosciences

Research and Development Team

Operations Team